This report provides exclusive insights into the COVID-19 impact on the Cystic Fibrosis. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Cystic Fibrosis. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Cystic Fibrosis. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on cystic fibrosis (CF) market provides in-depth
analysis of segments and sub-segments in the global as well as regional cystic
fibrosis market. The study also highlights the impact of drivers, restraints,
and macro indicators on the global and regional cystic fibrosis market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of the global cystic fibrosis market.
According to the report, the global cystic fibrosis market is projected to grow
at a CAGR of 16.6% over the forecast period of 2019-2025.
Cystic fibrosis is a genetic
disease that mainly affects the lung and digestive systems. The body produces
thick and sticky mucus that clog the lungs and obstruct the pancreas. The mucus
is difficult to cough out of the lungs and can make breathing difficult. The
growing prevalence of cystic fibrosis disease drives the growth of the cystic
fibrosis market. Cystic fibrosis is an inherited disorder that causes severe
damage to the lungs, digestive system, and other organs in the body. People
with cystic fibrosis, a defective gene causes the secretions to become sticky
and thick. Instead of acting as a lubricant, the secretions plug up tubes,
ducts, and passageways, especially in the lungs and pancreas. Improvements in
screening and treatments are the major factors contribute to the growth of the
cystic fibrosis therapeutics market. Due to improvements in screening and
treatments, mean people with cystic fibrosis now may live into their mid to the
late 30s, on average, and some are living into their 40s and 50s.
pathophysiology, high cost of treatment and an increase in genetic mutation
rate are some of the factors expected to hinder the growth of this market.
Furthermore, owing to continued extensive research and development activities,
varieties of medicines are expected to launch in the market in the future
period. Increasing global awareness for cystic fibrosis therapy, technological
advancements in the R&D is expected to provide beneficial opportunities for
the cystic fibrosis market.
Among the Geographies, North
America held the largest market share in 2017, owing to improve healthcare
infrastructure and healthcare policies. The U.S drives the North America
market, owing to an early screening of newborns for cystic fibrosis in every state
in the United States so that this condition can be diagnosed within the first
month of the life before symptoms develop. The European market is considered as
the most lucrative market for CF Therapeutics, followed by the North American
The report on global cystic
fibrosis market covers segments such as drug class and route of administration.
On the basis of drug class, the sub-markets include CFTR modulators, mucolytic,
pancreatic enzyme supplements, bronchodilators, and other drug classes. On the
basis of route of administration, the sub-markets include inhaled drugs and
The report provides profiles of
the companies in the market such as Alcresta Therapeutics, Inc., AstraZeneca
plc, Teva Pharmaceutical Industries, Allergan plc, Advanced Inhalation
Therapies (AIT) Ltd., F. Hoffmann-La Roche AG, Novartis International AG,
Gilead Sciences, Inc., Vertex Pharmaceuticals, Inc., AbbVie Inc., and Other
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the cystic fibrosis market. Moreover, the study highlights current
market trends and provides forecast from 2019-2025. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players.